Disease management: who needs it and why?

Mike Drummond ()
Additional contact information
Mike Drummond: Centre for Health Economics, The University of York

No 152chedp, Working Papers from Centre for Health Economics, University of York

Abstract: Disease management is attracting considerable attention from the pharmaceutical industry, which sees this as a way of extending its activities beyond drug development to health care management and organisation. However, it is unclear whether disease management offers advantages to the NHS or society more generally. This paper explores different interpretations of the term ‘disease management’ and assesses its likely advantages to the pharmaceutical industry and the NHS. It is concluded that the main attributes of disease management activities are that they encourage consideration of the full costs of disease, the cost-effectiveness of alternative approaches to diagnosis and treatment, and the development of innovative approaches to the provision of care. However, the NHS needs to make a careful assessment of whether partnerships with the pharmaceutical industry or any other party are likely to lead to increased efficiency. For this reason any disease management strategy should include a thorough examination of the costs and effectiveness of alternative health care treatments and programmes.

Keywords: disease management; pharmaceutical industry (search for similar items in EconPapers)
Pages: 21 pages
Date: 1997-03
References: View references in EconPapers View complete reference list from CitEc
Citations:

Downloads: (external link)
http://www.york.ac.uk/media/che/documents/papers/d ... on%20Paper%20152.pdf First version,1997 (application/pdf)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:chy:respap:152chedp

Access Statistics for this paper

More papers in Working Papers from Centre for Health Economics, University of York Contact information at EDIRC.
Bibliographic data for series maintained by Gill Forder ().